Literature DB >> 16216171

Pathogenesis of nasal polyps: an update.

Rafal Pawliczak1, Anna Lewandowska-Polak, Marek L Kowalski.   

Abstract

The cause of nasal polyp formation is still unknown. Genetic predisposition has been suggested, but there are scanty data to support such theories. Activated epithelial cells may be the major source of mediators inducing influx of inflammatory cells (mostly eosinophils) and proliferation and activation of fibroblasts leading to nasal polyp formation. Infectious agents (including viruses, bacteria, or fungi) may be potential primary factors activating nasal epithelial cells. Proinflammatory cytokines and growth factors play important roles in the persistence of mucosal inflammation associated with nasal polyps. Arachidonic acid metabolites seem to be particularly important in the pathogenesis of nasal polyps in patients with aspirin hypersensitivity rhinosinusitis/asthma syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216171     DOI: 10.1007/s11882-005-0027-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  74 in total

1.  Inflammatory cells in nasal mucosa and nasal polyps.

Authors:  S Morinaka; H Nakamura
Journal:  Auris Nasus Larynx       Date:  2000-01       Impact factor: 1.863

Review 2.  Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?

Authors:  M L Kowalski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Association of stem cell factor expression in nasal polyp epithelial cells with aspirin sensitivity and asthma.

Authors:  M L Kowalski; A Lewandowska-Polak; J Woźniak; A Ptasińska; A Jankowski; M Wagrowska-Danilewicz; M Danilewicz; R Pawliczak
Journal:  Allergy       Date:  2005-05       Impact factor: 13.146

4.  Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps.

Authors:  A Szczeklik; R J Gryglewski; E Olszewski; A Dembińska-Kiec; G Czerniawska-Mysik
Journal:  Pharmacol Res Commun       Date:  1977-05

5.  Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics.

Authors:  C Picado; J C Fernandez-Morata; M Juan; J Roca-Ferrer; M Fuentes; A Xaubet; J Mullol
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

6.  Nuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics.

Authors:  C Picado; G Bioque; J Roca-Ferrer; L Pujols; J Mullol; P Benitez; O Bulbena
Journal:  Allergy       Date:  2003-02       Impact factor: 13.146

7.  Nasal polyposis: a study of its association with airborne allergen hypersensitivity.

Authors:  R Asero; G Bottazzi
Journal:  Ann Allergy Asthma Immunol       Date:  2001-03       Impact factor: 6.347

8.  Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi.

Authors:  Seung-Heon Shin; Jens U Ponikau; David A Sherris; David Congdon; Evangelo Frigas; Henry A Homburger; Mark C Swanson; Gerald J Gleich; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

9.  Functional heterogeneity of mast cells isolated from different microenvironments within nasal polyp tissue.

Authors:  S Finotto; J Dolovich; J A Denburg; M Jordana; J S Marshall
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients.

Authors:  C Picado; I Ramis; J Rosellò; J Prat; O Bulbena; V Plaza; J M Montserrat; E Gelpí
Journal:  Am Rev Respir Dis       Date:  1992-01
View more
  18 in total

1.  Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Sarah Peterson; Julie A Poposki; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

Review 2.  Surgical versus medical interventions in CRS and nasal polyps: comparative evidence between medical and surgical efficacy.

Authors:  Osama Dessouky; Claire Hopkins
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

3.  Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps.

Authors:  Julie A Poposki; Ashraf Uzzaman; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

4.  Aberrant expression of miR-663 and transforming growth factor-β1 in nasal polyposis in children.

Authors:  Hailing Yu; Jianbao Ju; Jingdong Liu; Da Li
Journal:  Exp Ther Med       Date:  2018-03-06       Impact factor: 2.447

5.  Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Kathryn E Hulse; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2013-03-28       Impact factor: 10.793

6.  A pilot study of symptom profiles from a polyp vs an eosinophilic-based classification of chronic rhinosinusitis.

Authors:  Christopher F Thompson; Caroline P E Price; Julia He Huang; Jin-Young Min; Lydia A Suh; Stephanie Shintani-Smith; David B Conley; Robert P Schleimer; Robert C Kern; Bruce K Tan
Journal:  Int Forum Allergy Rhinol       Date:  2015-12-18       Impact factor: 3.858

Review 7.  The Role of Small Extracellular Vesicles and MicroRNAs in the Diagnosis and Treatment of Allergic Rhinitis and Nasal Polyps.

Authors:  Yiting Liu; Jichao Sha; Cuida Meng; Dongdong Zhu
Journal:  Mediators Inflamm       Date:  2022-06-16       Impact factor: 4.529

8.  Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression.

Authors:  Tetsuji Takabayashi; Atsushi Kato; Anju T Peters; Kathryn E Hulse; Lydia A Suh; Roderick Carter; James Norton; Leslie C Grammer; Seong H Cho; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Shigeharu Fujieda; Robert P Schleimer
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

9.  Eosinophil Chemokines and Clara Cell Protein 16 Production in Nasal Mucosa of Patients with Persistent Allergic Rhinitis.

Authors:  Aleksandar Perić; Cveta Špadijer Mirković; Biserka Vukomanović Đurđević; Aneta V Perić; Danilo Vojvodić
Journal:  Eurasian J Med       Date:  2017-10

10.  Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination.

Authors:  Hendrik Graefe; Christina Roebke; Dirk Schäfer; Jens Eduard Meyer
Journal:  J Allergy (Cairo)       Date:  2012-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.